Repurposing Niclosamide Ethanolamine for Alveolar Echinococcosis Reveals a Disconnect Between In Vitro Efficacy and In Vivo Outcome
Matías Preza, Nicole L. Dietrich, Pascal Zumstein, Judith Steinmann, Lea Anna Hiller, Trix Zumkehr, Tobias Kämpfer, Marylène Chollet‐Krugler, Laura Vetter, Andrew Frederick Hemphill, Sarah Dion, Britta Lundström‐Stadelmann
This study tests niclosamide ethanolamine (NEN) as a treatment for alveolar echinococcosis, finding strong in vitro efficacy but no significant in vivo effect in mice.
bioRxiv · Feb 10, 2026 · PreprintPharmacology & Toxicology